跳至主要内容
临床试验/NCT00775957
NCT00775957终止不适用

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma

University of Oklahoma1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
35
试验地点
1
主要终点
Staging and ReStaging scans

研究概览

简要总结

A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.

详细描述

The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing imaging with both FLT and FDG PET.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Women must not be pregnant or breast feeding
  • Histologic diagnosis of non-Hodgkin's lymphoma (any stage)
  • Must undergo treatment with chemotherapy and/or radiotherapy

排除标准

  • May not have received previous therapy with radiopharmaceuticals
  • May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal antibodies

结局指标

主要结局

Staging and ReStaging scans

时间窗: after hematopoetic recovery

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验